[HTML] annchildneurol.org

[HTML][HTML] The efficacy and safety of rituximab for the treatment of pediatric autoimmune neuroinflammatory disorders at a single center

YJ Ko, YK Shim, WJ Kim, SY Kim, H Kim… - Annals of Child …, 2020 - annchildneurol.org
Purpose Rituximab is increasingly used as a second-line treatment of neuroinflammatory
disorders to improve clinical outcomes in cases refractory to conventional immunotherapy …
被引用次数：2 相关文章
[PDF] semanticscholar.org

[PDF][PDF] The Efficacy and Safety of Rituximab for the Treatment of Pediatric Autoimmune Neuroinflammatory Disorders at a Single Center

MD Hee Hwang, MD Jong-Hee Chae… - Ann Child …, 2020 - pdfs.semanticscholar.org
Purpose: Rituximab is increasingly used as a second-line treatment of neuroinflammatory
disorders to improve clinical outcomes in cases refractory to conventional immunotherapy …

The efficacy and safety of rituximab for the treatment of pediatric autoimmune neuroinflammatory disorders at a single center

YJ Ko, YK Shim, WJ Kim, SY Kim… - Annals of Child …, 2020 - snucm.elsevierpure.com
Purpose: Rituximab is increasingly used as a second-line treatment of neuroinflammatory
disorders to improve clinical outcomes in cases refractory to conventional immunotherapy …
[PDF] archive.org

[PDF][PDF] The Efficacy and Safety of Rituximab for the Treatment of Pediatric Autoimmune Neuroinflammatory Disorders at a Single Center

MD Hee Hwang, MD Jong-Hee Chae… - Ann Child …, 2020 - scholar.archive.org
Purpose: Rituximab is increasingly used as a second-line treatment of neuroinflammatory
disorders to improve clinical outcomes in cases refractory to conventional immunotherapy …
[HTML] annchildneurol.org

[HTML][HTML] The Efficacy and Safety of Rituximab for the Treatment of Pediatric Autoimmune Neuroinflammatory Disorders at a Single Center

YJ Ko, YK Shim, WJ Kim, SY Kim, H Kim… - Annals of Child …, 2020 - annchildneurol.org
Purpose Rituximab is increasingly used as a second-line treatment of neuroinflammatory
disorders to improve clinical outcomes in cases refractory to conventional immunotherapy …
[HTML] annchildneurol.org

[HTML][HTML] The Efficacy and Safety of Rituximab for the Treatment of Pediatric Autoimmune Neuroinflammatory Disorders at a Single Center

YJ Ko, YK Shim, WJ Kim, SY Kim, H Kim… - Annals of Child …, 2020 - annchildneurol.org
Purpose Rituximab is increasingly used as a second-line treatment of neuroinflammatory
disorders to improve clinical outcomes in cases refractory to conventional immunotherapy …

The Efficacy and Safety of Rituximab for the Treatment of Pediatric Autoimmune Neuroinflammatory Disorders at a Single Center

YJ Ko, YK Shim, WJ Kim, SY Kim… - Annals of Child …, 2020 - oldkmbase.medric.or.kr
Purpose: Rituximab is increasingly used as a second-line treatment of neuroinflammatory
disorders to improve clinical outcomes in cases refractory to conventional immunotherapy …

The Efficacy and Safety of Rituximab for the Treatment of Pediatric Autoimmune Neuroinflammatory Disorders at a Single Center

YJ Ko, YK Shim, WJ Kim, SY Kim, H Kim, H Hwang… - Annals of Child … - KoreaMed
Purpose Rituximab is increasingly used as a second-line treatment of neuroinflammatory
disorders to improve clinical outcomes in cases refractory to conventional immunotherapy …

The Efficacy and Safety of Rituximab for the Treatment of Pediatric Autoimmune Neuroinflammatory Disorders at a Single Center

YJ Ko, YK Shim, WJ Kim, SY Kim… - Annals of Child …, 2020 - scholar.kyobobook.co.kr
Purpose: Rituximab is increasingly used as a second-line treatment of neuroinflammatory
disorders to improve clinical outcomes in cases refractory to conventional immunotherapy …

The Efficacy and Safety of Rituximab for the Treatment of Pediatric Autoimmune Neuroinflammatory Disorders at a Single Center

YJ Ko, YK Shim, WJ Kim, SY Kim… - Annals of Child …, 2020 - oldkmbase.medric.or.kr
Purpose: Rituximab is increasingly used as a second-line treatment of neuroinflammatory
disorders to improve clinical outcomes in cases refractory to conventional immunotherapy …